Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphoma. (Q53634516)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphoma. |
scientific article |
Statements
Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphoma. (English)
Asher Chanan-Khan
Tariq Islam
Arif Alam
Kena C Miller
John Gibbs
Maurice Barcos
Myron S Czuczman
Pamela Paplham
Theresa Hahn
Philip McCarthy
1 August 2004
45
8
1673-1675
1 reference
1 reference
1 reference
1 reference
1 reference